Ac Medical T. Ciacka sp. k. (Poland)

Main Activities: Ambulatory Health Care Services

Secondary Activities: Pharmacies and Drug Stores | Lessors of Real Estate | Rental and Leasing Services | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Schools and Instruction | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services

Full name: Ac Medical T. Ciacka sp. k.

Profile Updated: April 24, 2025

Ac Medical T. Ciacka sp. k. is based in Poland. The head office is in Stara Wies. The company operates in the Ambulatory Health Care Services sector. Ac Medical T. Ciacka sp. k. was incorporated on June 21, 2022. The latest financial highlights indicate a net sales revenue increase of 29.65% in 2025. Its total assets grew by 76.9% over the same period. The net profit margin of Ac Medical T. Ciacka sp. k. increased by 6.7% in 2025.

Headquarters
Ul. Limonkowa 1
Stara Wies; Mazowieckie; Postal Code: 05-830

Contact Details: Purchase the Ac Medical T. Ciacka sp. k. report to view the information.

Basic Information

Financial Auditors:

Purchase the Ac Medical T. Ciacka sp. k. report to view the information.

Incorporation Date:

June 21, 2022

Key Executives

Purchase this report to view the information.

Associate Partner

Purchase this report to view the information.

Limited Partner

Company Performance

Financial values in the chart are available after Ac Medical T. Ciacka sp. k. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

29.65%▲

Total Operating Revenue

29.66%▲

Operating Profit

61.83%▲

EBITDA

62.71%▲

Net Profit/Loss for the Period

61.8%▲

Total Assets

76.9%▲

Total Equity

145.36%▲

Operating Profit Margin

7.36%▲

Net Profit Margin

6.7%▲

Return on Equity (ROE)

-61.82%▼

Similar companies

Related EMIS Industry Reports